Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
AFJK Stock Forecast 2026-2027
$41.38
Current Price
$249.77M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to AFJK Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
AFJK Price Momentum
-19.2%
1 Week Change
+50.5%
1 Month Change
+276.2%
1 Year Change
-35.4%
Year-to-Date Change
-68.3%
From 52W High of $130.37
+513.0%
From 52W Low of $6.75
📊 TOP ANALYST CALLS
Did AFJK Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Aimei Health is one of their latest high-conviction picks.
Latest AFJK Stock Price Targets & Analyst Predictions
AFJK has shown a year-to-date change of -35.4% and a 1-year change of 276.2%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for AFJK. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AFJK Analyst Ratings
0
Buy
0
Hold
0
Sell
AFJK Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $41.38
Latest AFJK Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AFJK.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Aimei Health Technology Co., Ltd. (AFJK) Competitors
The following stocks are similar to Aimei Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Aimei Health Technology Co., Ltd. (AFJK) Financial Data
Aimei Health Technology Co., Ltd. has a market capitalization of $249.77M with a P/E ratio of 223.6x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of +3.5%.
Valuation Metrics
Market Cap
$249.77M
Enterprise Value
$279.03M
P/E Ratio
223.6x
PEG Ratio
-8.9x
Price/Sales
N/A
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
EPS Growth
-52.7%
Financial Health
Cash/Price Ratio
+0.0%
Current Ratio
0.0x
Debt/Equity
0.0x
ROE
+3.5%
ROA
-1.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Aimei Health Technology Co., Ltd. (AFJK) Business Model
About Aimei Health Technology Co., Ltd.
What They Do
A SPAC focused on healthcare sector acquisitions.
Business Model
The company operates as a special purpose acquisition company (SPAC), primarily raising capital through its initial public offering (IPO) to facilitate mergers and acquisitions in the healthcare sector and beyond. It holds the raised funds in a trust account until it identifies a suitable business combination, enabling it to generate returns for investors upon successful completion of these transactions.
Additional Information
In 2023, Aimei Health Technology Co., Ltd. has entered into a definitive agreement to merge with United Hydrogen Group Inc., aiming to create a combined public entity. As a shell company classified in the financial services sector, it provides private businesses with access to public markets through the SPAC model.
Aimei Health Technology Co., Ltd. (AFJK) Latest News & Analysis
Latest News
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED ANNUAL REPORT
20 hours ago
Quick Summary
Aimei Health Technology (Nasdaq: AFJK) is not compliant with Nasdaq listing rules due to a delay in filing its 2025 Annual Report, which was due March 31, 2026.
Why It Matters
Aimei Health's non-compliance with Nasdaq listing rules due to delayed financial reporting raises concerns over transparency and financial health, potentially affecting stock value and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Aimei Health Technology (NASDAQ: AFJK) stock is down despite announcing a $1.6 billion SPAC merger with United Hydrogen Group, which will go public under a new ticker.
Why It Matters
Aimei Health Technology's stock drop despite a significant SPAC merger indicates potential investor skepticism or concerns about the deal's long-term value, affecting market sentiment.
Source: InvestorPlace
Market Sentiment:
Neutral
Quick Summary
United Hydrogen Group plans to list on Nasdaq through a blank-check merger, valuing the company at $1.6 billion.
Why It Matters
United Hydrogen Group's Nasdaq listing via a SPAC merger at a $1.6 billion valuation signals growth potential in green energy, attracting investor interest in sustainable technologies.
Source: Reuters
Market Sentiment:
Positive
Frequently Asked Questions About AFJK Stock
What is Aimei Health Technology Co., Ltd.'s (AFJK) stock forecast for 2026?
Analyst forecasts for Aimei Health Technology Co., Ltd. (AFJK) are not currently available. The stock is trading at $41.38.
Is AFJK stock a good investment in 2026?
Analyst ratings for AFJK are not currently available. The stock is currently trading at $41.38. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AFJK stock?
Price predictions from Wall Street analysts for AFJK are not currently available. The stock is trading at $41.38.
What is Aimei Health Technology Co., Ltd.'s business model?
The company operates as a special purpose acquisition company (SPAC), primarily raising capital through its initial public offering (IPO) to facilitate mergers and acquisitions in the healthcare sector and beyond. It holds the raised funds in a trust account until it identifies a suitable business combination, enabling it to generate returns for investors upon successful completion of these transactions.
What is the highest forecasted price for AFJK Aimei Health Technology Co., Ltd.?
Price targets from Wall Street analysts for AFJK are not currently available. The stock is trading at $41.38.
What is the lowest forecasted price for AFJK Aimei Health Technology Co., Ltd.?
Price targets from Wall Street analysts for AFJK are not currently available. The stock is trading at $41.38.
What is the overall AFJK consensus from analysts for Aimei Health Technology Co., Ltd.?
Analyst ratings for AFJK are not currently available. The stock is trading at $41.38.
How accurate are AFJK stock price projections?
Stock price projections, including those for Aimei Health Technology Co., Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 22, 2026 2:02 AM UTC